Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription


2 Acta Neuropathol
3 Alzheimers Dement
1 Am J Alzheimers Dis Other Demen
1 Brain
2 Brain Res
1 Exp Gerontol
1 Geriatrics (Basel)
12 J Alzheimers Dis
1 J Am Geriatr Soc
1 J Biol Chem
1 J Neurochem
1 Neurobiol Aging
1 Neuroscience
2 PLoS Genet
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neuropathol

  1. SHI Y, Murzin AG, Falcon B, Epstein A, et al
    Correction to: Cryo-EM structures of tau filaments from Alzheimer's disease with PET ligand APN-1607.
    Acta Neuropathol. 2021 Apr 8. pii: 10.1007/s00401-021-02303.

  2. TOME SO, Gomes LA, Li X, Vandenberghe R, et al
    TDP-43 interacts with pathological tau protein in Alzheimer's disease.
    Acta Neuropathol. 2021 Apr 2. pii: 10.1007/s00401-021-02295.

    Alzheimers Dement

  3. PROKOPENKO D, Morgan SL, Mullin K, Hofmann O, et al
    Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development.
    Alzheimers Dement. 2021 Apr 2. doi: 10.1002/alz.12319.
    PubMed         Abstract available

  4. MOELLER S, Sridhar J, Martersteck A, Coventry C, et al
    Functional decline in the aphasic variant of Alzheimer's disease.
    Alzheimers Dement. 2021 Apr 8. doi: 10.1002/alz.12331.
    PubMed         Abstract available

  5. MOLONEY CM, Lowe VJ, Murray ME
    Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.
    Alzheimers Dement. 2021 Apr 2. doi: 10.1002/alz.12321.
    PubMed         Abstract available

    Am J Alzheimers Dis Other Demen

  6. ABBATEMARCO JR, Jones SE, Larvie M, Bekris LM, et al
    Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype.
    Am J Alzheimers Dis Other Demen. 2021;36:1533317520981225.
    PubMed         Abstract available


  7. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.

    Brain Res

  8. PORTE B, Marguerit G, Thomasseau S, Paquet C, et al
    Dose-dependent neuroprotective effect of the JNK inhibitor Brimapitide in 5xFAD transgenic mice.
    Brain Res. 2020;1727:146587.
    PubMed         Abstract available

  9. PLANAS-FONTANEZ TM, Sainato DM, Sharma I, Dreyfus CF, et al
    Roles of astrocytes in response to aging, Alzheimer's Disease and Multiple Sclerosis.
    Brain Res. 2021 Apr 1:147464. doi: 10.1016/j.brainres.2021.147464.
    PubMed         Abstract available

    Exp Gerontol

  10. TZEKAKI EE, Tsolaki M, Pantazaki AlphaA, Geromichalos G, et al
    The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system.
    Exp Gerontol. 2021 Apr 6:111344. doi: 10.1016/j.exger.2021.111344.
    PubMed         Abstract available

    Geriatrics (Basel)

  11. POIRIER G, Ohayon A, Juranville A, Mourey F, et al
    Deterioration, Compensation and Motor Control Processes in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease.
    Geriatrics (Basel). 2021;6.
    PubMed         Abstract available

    J Alzheimers Dis

  12. TEITSDOTTIR UD, Halldorsson S, Rolfsson O, Lund SH, et al
    Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.
    J Alzheimers Dis. 2021 Mar 25. pii: JAD200964. doi: 10.3233/JAD-200964.
    PubMed         Abstract available

  13. AITKEN WW, Lombard J, Wang K, Toro M, et al
    Relationship of Neighborhood Greenness to Alzheimer's Disease and Non-Alzheimer's Dementia Among 249,405 U.S. Medicare Beneficiaries.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201179. doi: 10.3233/JAD-201179.
    PubMed         Abstract available

  14. LI LL, Ma YH, Bi YL, Sun FR, et al
    Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201192. doi: 10.3233/JAD-201192.
    PubMed         Abstract available

  15. ZHENG YM, Zhao YY, Zhang T, Hou XH, et al
    Left Ventricular Ejection Fraction and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Normal Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201222. doi: 10.3233/JAD-201222.
    PubMed         Abstract available

  16. MARRA C, Piccininni C, Iacobucci GM, Caprara A, et al
    Semantic Memory as an Early Cognitive Marker of Alzheimer's Disease: Role of Category and Phonological Verbal Fluency Tasks.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD201452. doi: 10.3233/JAD-201452.
    PubMed         Abstract available

  17. ZHOU Y, Wang Y, Quan M, Zhao H, et al
    Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201497. doi: 10.3233/JAD-201497.
    PubMed         Abstract available

  18. BOSTROM G, Freyhult E, Virhammar J, Alcolea D, et al
    Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201565. doi: 10.3233/JAD-201565.
    PubMed         Abstract available

  19. PILLAI JA, Bena J, Bekris LM, Foldvary-Schaefer N, et al
    Unique Sleep and Circadian Rhythm Dysfunction Neuroinflammatory and Immune Profiles in Alzheimer's Disease with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201573. doi: 10.3233/JAD-201573.
    PubMed         Abstract available

  20. O'BRYANT S, Zhang F, Petersen M, Johnson L, et al
    A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201610. doi: 10.3233/JAD-201610.
    PubMed         Abstract available

  21. FENG LIU Q, Kanmani S, Lee J, Kim GW, et al
    Neoline Improves Memory Impairment and Reduces Amyloid-beta Level and Tau Phosphorylation Through AMPK Activation in the Mouse Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Mar 26. pii: JAD201614. doi: 10.3233/JAD-201614.
    PubMed         Abstract available

  22. HASHIMOTO M, Ho G, Sugama S, Takenouchi T, et al
    Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD210206. doi: 10.3233/JAD-210206.
    PubMed         Abstract available

  23. QIU H, Zhao R, Fei G, Pan X, et al
    Dynamic Change of Intracellular Metabolism of Microglia Evaluated by Transcriptomics in an Alzheimer's Mouse Model.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD210213. doi: 10.3233/JAD-210213.
    PubMed         Abstract available

    J Am Geriatr Soc

  24. NOEL V, Mouchoux C, Krolak-Salmon P, Novais T, et al
    Evolution in the dispensation of drugs for Alzheimer's disease after removal from the list of reimbursable drugs in France.
    J Am Geriatr Soc. 2021 Apr 5. doi: 10.1111/jgs.17151.

    J Biol Chem

  25. VILALTA A, Zhou Y, Sevalle J, Griffin JK, et al
    Wild-type sTREM2 blocks Abeta aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Abeta aggregation.
    J Biol Chem. 2021 Apr 3:100631. doi: 10.1016/j.jbc.2021.100631.
    PubMed         Abstract available

    J Neurochem

  26. VAN DER VELPEN V, Rosenberg N, Maillard V, Teav T, et al
    Sex-specific alterations in NAD+ metabolism in triple transgenic Alzheimer's disease mouse brain assessed by quantitative targeted liquid chromatography - mass spectrometry.
    J Neurochem. 2021 Apr 8. doi: 10.1111/jnc.15362.
    PubMed         Abstract available

    Neurobiol Aging

  27. CACCIOTTOLO M, Morgan TE, Finch CE
    Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice.
    Neurobiol Aging. 2021;103:42-51.
    PubMed         Abstract available


  28. NAZANIN HAJJARI S, Sadigh-Eteghad S, Shanehbandi D, Teimourian S, et al
    MicroRNA-4422-5p as a Negative Regulator of Amyloidogenic Secretases: A Potential Biomarker for Alzheimer's disease.
    Neuroscience. 2021 Apr 6. pii: S0306-4522(21)00163.
    PubMed         Abstract available

    PLoS Genet

  29. NACKENOFF AG, Hohman TJ, Neuner SM, Akers CS, et al
    PLD3 is a neuronal lysosomal phospholipase D associated with beta-amyloid plaques and cognitive function in Alzheimer's disease.
    PLoS Genet. 2021;17:e1009406.
    PubMed         Abstract available

  30. TANG S, Buchman AS, De Jager PL, Bennett DA, et al
    Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer's dementia.
    PLoS Genet. 2021;17:e1009482.
    PubMed         Abstract available

    PLoS One

  31. KIM D, Lee JH, Kim HY, Shin J, et al
    Correction: Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
    PLoS One. 2021;16:e0250194.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.